patient recruitment

Drug discovery predictions: Analysis and insight

Drug Discovery Predictions: Analysis and Insight

In this Drug Discovery World article, author Megan Thomas spoke with decision makers from the clinical trial industry, including Clincierge’s CEO, Scott Gray, about their predictions on what 2022 holds for our sector, including the importance of patient-centricity and improved stakeholder engagement in clinical trials.

SCRS_INSITE_AMPLIFYING_THE_VOICE_OF_THE_PATIENT_IN_RARE_DISEASE_TRIALS

Amplifying the Voice of the Patient in Rare Disease Trials

Featured in SCRS InSite Journal: Scott Gray, CEO, discusses patient recruitment and retention, two of the most pressing challenges facing clinical research today. Continue reading to learn more about understanding the financial, logistical, and emotional barriers to participation, the consequences of poor retention and enrollment, actionable steps to improve trial outcomes, and other key findings …

Amplifying the Voice of the Patient in Rare Disease Trials Read More »

Scott Gray named 2022 Philadelphia Titan 100

Scott Gray Named 2022 Philadelphia Titan 100

PHILADELPHIA, July 5, 2022 – Titan CEO and headline sponsor Wipfli LLP are pleased to announce the 2022 Philadelphia Titan 100. The Titan 100 program recognizes Philadelphia’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished business leaders in their industry using criteria that includes demonstrating exceptional leadership, vision, and passion.

error: Protected content.

Voice of the Patient Research

View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.

Voice of the patient